MedPath
PPB Approval

APO-ERLOTINIB TABLETS 25MG

HK-67874

Prescription only Medicines

June 30, 2023

Company Information

Company Details

UNIT 3B 11/F BLK B SEAVIEW ESTATE, 2-8 WATSON RD, NORTH POINT, HONG KONG

Active Ingredients

erlotinib (as hydrochloride)

Drug Monographs

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-ERLOTINIB TABLETS 25MG - PPB 批准文号 | MedPath